Support for Clinical Trials Advancing Rare Disease Therapeutics
-
Bala Cynwyd-Based Larimar Therapeutics Chosen for FDA’s START Pilot Program
The Food and Drug Administration has selected Bala Cynwyd-based Larimar Therapeutics’ lead drug candidate for its new program inspired by…
Founding Partners
Advertisement
Affiliate Partners
Community Partners
